As of 2025-07-09, the Relative Valuation of Intellia Therapeutics Inc (NTLA) is (70.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.12 USD, the upside of Intellia Therapeutics Inc based on Relative Valuation is -737.0%.
The range of the Relative Valuation is (69.86) - (97.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 19.3x | 14.2x |
| Forward P/E multiples | 13.1x - 21.3x | 13.7x |
| Fair Price | (69.86) - (97.89) | (70.83) |
| Upside | -728.3% - -980.3% | -737.0% |
| Date | P/E |
| 2025-07-08 | -2.19 |
| 2025-07-07 | -2.02 |
| 2025-07-03 | -2.12 |
| 2025-07-02 | -2.11 |
| 2025-07-01 | -1.95 |
| 2025-06-30 | -1.85 |
| 2025-06-27 | -1.88 |
| 2025-06-26 | -1.89 |
| 2025-06-25 | -1.88 |
| 2025-06-24 | -1.88 |
| 2025-06-23 | -1.82 |
| 2025-06-20 | -1.81 |
| 2025-06-18 | -1.89 |
| 2025-06-17 | -1.89 |
| 2025-06-16 | -1.76 |
| 2025-06-13 | -1.64 |
| 2025-06-12 | -1.64 |
| 2025-06-11 | -1.65 |
| 2025-06-10 | -1.67 |
| 2025-06-09 | -1.63 |
| 2025-06-06 | -1.59 |
| 2025-06-05 | -1.49 |
| 2025-06-04 | -1.51 |
| 2025-06-03 | -1.51 |
| 2025-06-02 | -1.41 |
| 2025-05-30 | -1.35 |
| 2025-05-29 | -1.47 |
| 2025-05-28 | -1.90 |
| 2025-05-27 | -1.84 |
| 2025-05-23 | -1.80 |
| 2025-05-22 | -1.86 |
| 2025-05-21 | -1.81 |
| 2025-05-20 | -1.90 |
| 2025-05-19 | -1.78 |
| 2025-05-16 | -1.67 |
| 2025-05-15 | -1.59 |
| 2025-05-14 | -1.55 |
| 2025-05-13 | -1.64 |
| 2025-05-12 | -1.68 |
| 2025-05-09 | -1.60 |
| 2025-05-08 | -1.63 |
| 2025-05-07 | -1.44 |
| 2025-05-06 | -1.43 |
| 2025-05-05 | -1.66 |
| 2025-05-02 | -1.74 |
| 2025-05-01 | -1.70 |
| 2025-04-30 | -1.75 |
| 2025-04-29 | -1.62 |
| 2025-04-28 | -1.67 |
| 2025-04-25 | -1.64 |